Dacetuzumab
|
WikiDoc Resources for Dacetuzumab |
|
Articles |
|---|
|
Most recent articles on Dacetuzumab Most cited articles on Dacetuzumab |
|
Media |
|
Powerpoint slides on Dacetuzumab |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Dacetuzumab at Clinical Trials.gov Clinical Trials on Dacetuzumab at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Dacetuzumab
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Dacetuzumab Discussion groups on Dacetuzumab Patient Handouts on Dacetuzumab Directions to Hospitals Treating Dacetuzumab Risk calculators and risk factors for Dacetuzumab
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Dacetuzumab |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Dacetuzumab is a humanized monoclonal antibody used to treat cancer.
Template:Humanizedmonoclonals Template:WH Template:WikiDoc Sources